tiprankstipranks
Trending News
More News >
Flowserve Corp (FLS)
NYSE:FLS

Flowserve (FLS) AI Stock Analysis

Compare
460 Followers

Top Page

FLS

Flowserve

(NYSE:FLS)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
$95.00
▲(6.81% Upside)
Action:ReiteratedDate:02/07/26
Overall score reflects improving financial performance (strong margin and ROE expansion) and a generally constructive earnings outlook (2026 EPS and margin expansion guidance with capital returns). The score is tempered by a stretched technical setup (overbought RSI/stochastic) and a relatively expensive valuation (P/E ~29.9 with ~1.0% yield), plus some near-term execution/timing risk in OE and backlog conversion.
Positive Factors
Margin Expansion / Profitability
Sustained, multi-year margin improvement reflects durable operational leverage from higher-margin aftermarket and product mix, showing the company can convert revenue into cash profits. Higher margins improve reinvestment ability, support buybacks, and create buffer versus cyclical top-line swings.
Recurring Aftermarket Revenue
A large and growing aftermarket (service, maintenance, spare parts) drives recurring, higher-margin revenue and steadier cash flow versus project-driven OEM sales. This strengthens customer stickiness, improves revenue predictability, and supports long-term returns and valuation resilience.
Strategic M&A and Nuclear Positioning
Targeted deals expand addressable market in mission-critical valves and nuclear service, increasing installed base and aftermarket opportunity per project. Structural exposure to nuclear and critical infrastructure can lift long-term content per project and recurring service revenue if projects proceed.
Negative Factors
Elevated Leverage
Material debt levels leave Flowserve more sensitive to economic slowdowns and rising rates, constraining flexibility for organic investment or additional M&A without increasing leverage. Servicing and refinancing risk can pressure cash allocation in downturns.
Cash Flow Volatility
Irregular operating and free cash flow, driven by working-capital swings and prior negative years, reduces predictability of self-funding capacity. Volatility can limit consistent capital returns, increase reliance on debt, and complicate funding of capex or acquisitions.
Backlog Conversion & Project Timing Risk
Lower backlog conversion and reliance on long-duration nuclear projects shifts revenue and earnings into the back half, raising execution risk. If nuclear build-outs underperform or timing slips, top-line and cash generation could be materially delayed versus plan.

Flowserve (FLS) vs. SPDR S&P 500 ETF (SPY)

Flowserve Business Overview & Revenue Model

Company DescriptionFlowserve Corporation designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia, and internationally. It operates in two segments, Flowserve Pump Division (FPD) and Flow Control Division (FCD). The FPD segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades, and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, re-rate and upgrade solutions, retrofit programs, and machining and asset management solutions, as well as manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines. The FCD segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls, and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs, and field machining capabilities. This segment's products are used to control, direct, and manage the flow of liquids, gases, and fluids. The company primarily serves oil and gas, chemical and pharmaceuticals, power generation, and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was incorporated in 1912 and is headquartered in Irving, Texas.
How the Company Makes MoneyFlowserve generates revenue through the sale of its extensive range of products and services, which include engineered pumps, valves, seals, and aftermarket services. The company's revenue model is built on both product sales and service contracts, with significant earnings derived from the installation, maintenance, and repair of its products. Key revenue streams include the manufacturing and distribution of fluid motion and control solutions, as well as long-term service agreements that ensure ongoing support and maintenance for customers. Flowserve has established partnerships with major players in the energy and industrial sectors, which further contribute to its revenue through collaborative projects and joint ventures. Additionally, the company benefits from a strong global presence, allowing it to tap into various regional markets and capitalize on growing demand for energy-efficient and reliable fluid management solutions.

Flowserve Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Chart Insights
Data provided by:The Fly

Flowserve Earnings Call Summary

Earnings Call Date:Feb 05, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 04, 2026
Earnings Call Sentiment Positive
The call emphasized strong operational execution with significant margin expansion, robust free cash flow, disciplined capital returns, and strategic M&A that enhance aftermarket and nuclear exposure. These positive developments and clear targets outweigh near-term revenue headwinds tied to OE project timing, a lower backlog conversion profile driven by longer nuclear projects, and softer FCD bookings. Management provided constructive 2026 guidance and reiterated long-term targets, while acknowledging front-half cadence risk and dependence on nuclear/power market execution.
Q4-2025 Updates
Positive Updates
Strong Margin Expansion and EPS Growth
Adjusted gross margin reached 36% in Q4, up 320 basis points year-over-year; adjusted operating margin expanded 420 basis points to 16.8%, exceeding the company's 2027 target range. Adjusted EPS for the quarter was $1.11, a 59% increase versus prior year; full-year adjusted EPS growth was ~38%.
Consistent Aftermarket Strength
Aftermarket bookings grew 10% in the quarter to $682 million (seventh consecutive quarter > $600M). Aftermarket sales increased 8% in the quarter and total aftermarket bookings for 2025 were $2.6 billion, +9% year-over-year.
Revenue and Organic Sales Performance
Total revenues in Q4 grew 4% year-over-year to $1.2 billion, with organic sales growth of roughly 1% and a ~240 basis point benefit from foreign currency translation.
Operating Cash Flow and Cash Return to Shareholders
Excluding asbestos divestiture impacts, Q4 cash from operations was $199 million with 121% free cash flow conversion. Full-year operating cash flow was $506 million, a 19% increase versus 2024. Returned $84 million in cash to shareholders in Q4 (including $57 million repurchases) and $365 million for the full year (including $255 million repurchases at an average $53/share); $200 million remains on the repurchase authorization.
Segment Margin Outperformance (FPD and FCD)
FPD adjusted gross margin rose 370 basis points to 37.1% and adjusted operating margin expanded to 21% (+350 bps); FPD bookings +8% with aftermarket +12% and FY Q4 sales of $833 million (FPD book-to-bill 1.06x). FCD adjusted gross margin improved 220 basis points to 34% and adjusted operating margin to 19.7% (+440 bps); Mogas acquisition delivered accretive margins.
2015–2025 Strategic Execution and M&A
Flowserve delivered its 2027 margin target two years ahead of plan and completed successful integrations (Mogas) using the Flowserve Business System. Announced acquisition of Trillium valve and actuation business (installed base >200,000 units, presence in 115 nuclear reactors) expected to increase content per new reactor by 15–20% (from ~$100M to ~$115–120M).
2026 Guidance and Longer-Term Targets
2026 guidance: reported sales growth 5–7% (organic 1–3%), ~100 bps FX tailwind, ~300 bps benefit from Greenray and Trillium; adjusted operating margin expected to expand ~100 bps; adjusted EPS guidance $4.00–$4.20 (~13% midpoint increase vs 2025). 2030 long-term targets: mid-single-digit organic CAGR (2025–2030) and 20% adjusted operating margins by 2030.
Backlog and Bookings for 2025
Total bookings for 2025 were $4.7 billion, including $400 million in nuclear awards. The company closed the year with a backlog of $2.9 billion and highlighted nearly $100 million of nuclear bookings in the quarter.
Negative Updates
Softness in Original Equipment and Project Timing
Original equipment (OE) revenues declined ~2% in the quarter; OE bookings were muted due to customer delays and timing of material receipts on percentage-of-completion projects. Company estimates ~50 basis points of Q4 revenue headwind from POC project timing, with impacts expected to persist into H1 2026.
Lower Backlog Conversion and Front-Loaded Revenue Risk
Company expects to convert ~76% of the existing backlog into revenue over the next 12 months (lower than recent years) due to a larger mix of longer-duration nuclear projects, implying more revenue and earnings weighted to the back half of the year (first half ~40% of full-year earnings).
FCD Bookings Weakness and Book-to-Bill Below 1.0
FCD bookings declined in the quarter (driven by 80/20 portfolio actions and project delays) and FCD's Q4 book-to-bill was 0.84x, signaling weaker order intake in that segment despite margin recovery.
Modest Organic Growth
Organic sales growth was only ~1% in Q4 and the 2026 organic growth guide of 1–3% is modest; management notes growth will be muted in H1 2026 and accelerate in H2, implying near-term top-line pressure.
Procurement / Timing Disruptions
Delays in timing of receipts (not a single-component procurement failure) affected percentage-of-completion revenue recognition at year-end and contributed to lower OE sales; while operational remedies are in place, timing risk remains near term.
Dependence on Nuclear and Macro Execution Risk
A material part of the company's growth thesis and acquisition rationale rests on nuclear and power end-market expansion. Management acknowledged that if nuclear build-out underperforms and growth skews toward other power sources, content per project could be lower and upside reduced—introducing execution and market-dependency risk.
Company Guidance
Flowserve guided to 2026 reported sales growth of 5%–7% (organic 1%–3%), including ~100 bps benefit from foreign exchange and roughly 300 bps benefit from the Greenray and assumed mid‑year Trillium Valves close, and expects bookings to grow mid‑single digits; adjusted operating margin is forecast to expand ~100 bps for the full year with adjusted EPS of $4.00–$4.20 (midpoint ≈ +13% vs. 2025) and an adjusted tax rate of 21%–22%; management expects to convert ~76% of current backlog into 2026 revenue (with OE activity accelerating in 2H), Q1 to be the lowest quarter and roughly 40% of full‑year EPS to be earned in H1, plans capital expenditures of $90–$100M, will at minimum repurchase shares to offset dilution (with ~$200M of buyback capacity remaining), and assumes Trillium will boost adjusted operating income while being neutral to adjusted EPS due to financing costs.

Flowserve Financial Statement Overview

Summary
Fundamentals are improving: revenue rose to $4.73B (2025) with meaningful margin expansion (net margin ~3.6% to ~7.3%; EBIT margin ~5.4% to ~12.8%) and ROE strengthening (~7.0% to ~15.8%). Offsetting this, leverage remains notable (~$1.91B debt; D/E ~0.87) and cash flow has been volatile (notably negative OCF/FCF in 2022 and weaker FCF growth in 2025 vs. 2024).
Income Statement
78
Positive
Flowserve shows a solid profitability and growth profile. Annual revenue increased from $3.54B (2021) to $4.73B (2025), with margins expanding meaningfully: gross margin improved from ~30.1% (2021) to ~33.4% (2025) and net margin rose from ~3.6% to ~7.3%. Operating profitability also strengthened (EBIT margin ~5.4% to ~12.8%), supporting a clear earnings recovery. The main watch-out is volatility in reported growth rates (including declines in 2020–2021 and unusually high growth shown in 2025), which suggests the top-line trajectory has not been consistently smooth year-to-year.
Balance Sheet
70
Positive
The balance sheet looks reasonable but moderately leveraged. Debt-to-equity improved from ~1.12 (2020) to ~0.87 (2025), indicating better capital structure over time, while equity grew to ~$2.19B (2025). Returns on equity strengthened from ~7.0% (2021) to ~15.8% (2025), consistent with improving profitability. The key weakness is that total debt remains sizable at ~$1.91B (2025), leaving the company more sensitive to downturns and financing costs than a lower-leverage peer.
Cash Flow
66
Positive
Cash generation is generally supportive but not fully consistent. Operating cash flow improved from $250M (2021) to $506M (2025) and free cash flow remained positive in most years, reaching $435M in 2025, with free cash flow running at ~86% of net income in 2025 (good earnings quality). However, 2022 was a clear blemish with negative operating cash flow (-$40M) and negative free cash flow (-$116M), and 2025 shows a sharp free cash flow decline versus 2024 (negative growth), signaling potential working-capital swings or elevated investment needs.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.73B4.56B4.32B3.62B3.54B
Gross Profit1.58B1.47B1.30B994.65M1.07B
EBITDA698.59M541.05M374.42M291.58M291.03M
Net Income346.25M282.76M186.74M188.69M125.95M
Balance Sheet
Total Assets5.71B5.50B5.11B4.79B4.75B
Cash, Cash Equivalents and Short-Term Investments760.18M675.44M545.68M434.97M658.45M
Total Debt1.91B1.69B1.40B1.46B1.50B
Total Liabilities3.45B3.45B3.13B2.93B2.91B
Stockholders Equity2.19B2.01B1.94B1.82B1.80B
Cash Flow
Free Cash Flow434.96M344.29M258.41M-116.30M195.18M
Operating Cash Flow505.88M425.31M325.77M-40.01M250.12M
Investing Cash Flow-125.16M-387.21M-68.58M-6.09M-59.48M
Financing Cash Flow-326.93M117.50M-153.01M-150.01M-599.71M

Flowserve Technical Analysis

Technical Analysis Sentiment
Positive
Last Price88.94
Price Trends
50DMA
76.79
Positive
100DMA
69.12
Positive
200DMA
60.52
Positive
Market Momentum
MACD
3.81
Negative
RSI
76.40
Negative
STOCH
74.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FLS, the sentiment is Positive. The current price of 88.94 is above the 20-day moving average (MA) of 83.05, above the 50-day MA of 76.79, and above the 200-day MA of 60.52, indicating a bullish trend. The MACD of 3.81 indicates Negative momentum. The RSI at 76.40 is Negative, neither overbought nor oversold. The STOCH value of 74.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLS.

Flowserve Risk Analysis

Flowserve disclosed 28 risk factors in its most recent earnings report. Flowserve reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Flowserve Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$17.63B33.5517.85%0.79%8.01%2.67%
77
Outperform
$12.04B51.4112.76%12.60%24.02%
75
Outperform
$31.30B29.2315.29%1.04%-5.24%45.69%
73
Outperform
$11.28B33.5316.49%1.17%3.19%69.89%
68
Neutral
$16.66B25.7017.48%0.96%0.83%-1.32%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
$14.50B52.014.27%0.97%-4.99%22.16%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FLS
Flowserve
88.94
34.90
64.59%
DOV
Dover
233.31
36.06
18.28%
ITT
ITT
206.47
66.98
48.02%
PNR
Pentair
102.03
10.35
11.29%
RRX
Regal Rexnord
215.36
83.03
62.74%
SPXC
SPX
242.29
108.73
81.41%

Flowserve Corporate Events

Business Operations and StrategyStock BuybackDividendsFinancial DisclosuresM&A Transactions
Flowserve Posts Strong 2025 Results, Announces Trillium Valves Deal
Positive
Feb 5, 2026

On February 5, 2026, Flowserve reported strong financial results for the fourth quarter and full year 2025, with Q4 bookings rising to $1.2 billion driven by 10% aftermarket growth, and full-year bookings reaching $4.7 billion, including about $400 million in nuclear awards. Reported sales grew 3.8% in 2025 to $4.73 billion, adjusted operating margin expanded to 14.8% from 11.8%, and adjusted EPS climbed 38.4% to $3.64, while cash from operations increased to $505.9 million, enabling the company to return $365 million to shareholders via dividends and repurchases. Despite a negative reported EPS in Q4 due to one-time asbestos divestiture impacts, adjusted Q4 operating margin reached 16.8% and adjusted EPS rose to $1.11, with management noting it achieved its 2027 adjusted operating margin target two years ahead of schedule. Flowserve also initiated 2026 guidance calling for 5%–7% total sales growth and adjusted EPS of $4.00–$4.20, and set 2030 targets that include mid-single-digit organic sales growth, roughly 20% adjusted operating margins and double-digit adjusted EPS growth, underscoring its confidence in healthy end markets and the momentum of its operational improvement programs. In addition, the company entered a definitive agreement on February 4, 2026, to acquire Trillium Flow Technologies’ Valves Division for $490 million in cash, a move that will expand Flowserve’s presence in nuclear, traditional power, industrial and critical infrastructure valves and actuators and is expected to be funded with a mix of cash and new debt, potentially strengthening its competitive position in mission-critical flow control applications once the deal closes, which is anticipated around mid-2026 subject to customary approvals.

The most recent analyst rating on (FLS) stock is a Buy with a $90.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.

Executive/Board Changes
Flowserve Announces Planned Board Transition as Director Departs
Neutral
Dec 30, 2025

On December 29, 2025, Flowserve Corporation announced that director Kenneth I. Siegel informed the board he will not stand for re-election at the company’s 2026 annual meeting of shareholders and will continue to serve as a director until that meeting. The company said Siegel’s decision was not due to any disagreement with management or the board, and the directors expressed their appreciation for his service and contributions, signaling an orderly and non-contentious board transition for stakeholders.

The most recent analyst rating on (FLS) stock is a Hold with a $80.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.

Financial DisclosuresM&A Transactions
Flowserve Completes Divestiture of Asbestos Liabilities
Negative
Dec 11, 2025

On December 11, 2025, Flowserve Corporation completed the divestiture of its legacy asbestos liabilities by selling its subsidiary BW/IP – New Mexico, Inc. to Ajax HoldCo LLC, an affiliate of Acorn Investment Partners. This transaction, which involved a total capitalization of approximately $219 million, allows Flowserve to remove these liabilities from its balance sheet and indemnifies the company from future financial exposure related to these liabilities. As a result, Flowserve expects a one-time loss of approximately $140 million in the fourth quarter of 2025, which will be excluded from adjusted earnings per share.

The most recent analyst rating on (FLS) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on Flowserve stock, see the FLS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026